For: | Ezzat WM, Amr KS. Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention. World J Hepatol 2016; 8(30): 1251-1261 [PMID: 27843535 DOI: 10.4254/wjh.v8.i30.1251] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v8/i30/1251.htm |
Number | Citing Articles |
1 |
M. Neamatallah, M. S. Serria, M. El‐Bendary, A.‐H. El‐Gilany, A. Alhawarey, S. Abed, Y. A. Setate, O. A. Ammar. Association of Vitamin D Gene Polymorphisms With HCV Infection Outcome. British Journal of Biomedical Science 2022; 79 doi: 10.3389/bjbs.2021.10237
|
2 |
Hasan Rahman Shawi Shawi, Enayat Anvari, Abolfazl Fateh. Role of FokI rs2228570 and Tru9I rs757343 Polymorphisms in the Mortality of Patients Infected with Different Variants of SARS-CoV-2. Archives of Medical Research 2023; 54(4): 310 doi: 10.1016/j.arcmed.2023.03.006
|
3 |
Micaela Parra, Natalia Laufer, Julieta M. Manrique, Leandro R. Jones, Jorge Quarleri. Phylogenetic Diversity in Core Region of Hepatitis C Virus Genotype 1a as a Factor Associated with Fibrosis Severity in HIV-1-Coinfected Patients. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1728456
|
4 |
Maria I. Poole, Inmaculada Sorribes, Harsh Vardhan Jain. Modeling hepatitis C virus protein and p53 interactions in hepatocytes: Implications for carcinogenesis. Mathematical Biosciences 2018; 306: 186 doi: 10.1016/j.mbs.2018.10.003
|
5 |
C Wendy Spearman, Geoffrey M Dusheiko, Margaret Hellard, Mark Sonderup. Hepatitis C. The Lancet 2019; 394(10207): 1451 doi: 10.1016/S0140-6736(19)32320-7
|
6 |
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals. Cancers 2022; 14(11): 2700 doi: 10.3390/cancers14112700
|
7 |
Mei Guo. Cellular senescence and liver disease: Mechanisms and therapeutic strategies. Biomedicine & Pharmacotherapy 2017; 96: 1527 doi: 10.1016/j.biopha.2017.11.075
|